United States: Handling Lawsuits For Fear Of Cancer From Toxic Torts

Courts must establish standards to ensure that such claims are genuine and objectively reasonable

Increasing numbers of plaintiffs are seeking emotional distress damages engendered by a fear of contracting cancer. In the toxic tort field, many fear-of-cancer lawsuits to date have involved complex claims of exposure to carcinogenic, or potentially carcinogenic, compounds, such as asbestos or petroleum additives. However, to date, only a few jurisdictions have established prima facie standards for this complex cause of action in the absence of a physical injury, and in arriving upon these standards, the courts have been challenged with the task of balancing competing public policy interests.

Despite improving medication and treatment, cancer remains a life-threatening illness that can result in emotional distress if one legitimately fears developing cancer. Moreover, because one person may develop cancer from a different level of exposure than another, and the latency period of cancer varies from person to person, it is possible that one could experience postexposure distress prior to being actually diagnosed with cancer.

Nevertheless, because of the confounding characteristics of cancer, a real potential for misapplication or abuse of this claim exists where a plaintiff's claimed emotional distress may be meritless or wholly speculative. Aside from the usual challenges of evaluating the veracity of an individual's claimed emotional distress, because of cancer's inconsistent genesis and latency periods, it is challenging for a fact-finder to evaluate whether a toxic exposure will cause the plaintiff to develop cancer at some point in time, which in turn makes it difficult to evaluate whether a plaintiff's emotional distress claim is reasonable. Even worse, an opportunistic or disingenuous plaintiff could use this uncertainty as an advantage, feigning emotional distress in order to secure a financial windfall. Due to the scientific uncertainty surrounding causes of cancer in humans, any person who has been exposed to a carcinogen could theoretically be entitled to fear-of-cancer damages without a legal standard providing guidance and limits to this cause of action.

Therefore, in balancing these legitimate interests for both sides, courts that have ruled on emotional distress claims for fear of cancer have ultimately set standards intended to ensure some measure of objectivity, reasonableness and genuineness by requiring proof of exposure, an objective belief that the plaintiff would contract the disease, and some measure of likelihood of contracting the disease. However, the proofs by which a plaintiff must prove an objectively reasonable fear vary from jurisdiction to jurisdiction. Below is a discussion of two seminal cases that set the standard for proving a prima facie case of fear of cancer, as well as the current state of New Jersey's fear-of-cancer law.

In Potter v. Firestone Tire and Rubber Co., the Supreme Court of California set what is widely regarded as the seminal standard regarding fear-of-cancer claims by requiring proof, in the absence of a present physical injury or illness, that: (1) the plaintiff was exposed to a toxic substance which threatens cancer, (2) the plaintiff's fear stems from a knowledge, corroborated by reliable medical or scientific opinion, that (3) it is more likely than not that the plaintiff will develop cancer in the future due to the toxic exposure. In striving to ensure that plaintiffs' fear-of-cancer claims are genuine and reasonable, the Potter court specifically rejected the argument that an exposure, or even a significant increase in the risk of cancer, is enough to recover fear-of-cancer damages where there is no showing of the actual likelihood of developing cancer due to exposure. The Potter court explained that "nearly everybody is exposed to carcinogens which appear naturally in all types of foods. Yet ordinary consumption for such foods is not substantially likely to result in cancer. Nor is the knowledge of such consumption likely to result in a reasonable fear of cancer."

In 2013, the Maryland Court of Appeals set the most recent standard for fear-of-cancer claims in the case of Exxon Mobil Corp. v. Albright. Until this litigation, no legal standard for emotional distress from fear of cancer existed under Maryland law, but the lower courts had awarded significant financial damages to numerous residential plaintiffs with respect to their fear-of-cancer claims stemming from alleged contamination of their well water as a result of a significant gasoline leak from a nearby gas station.

On appeal, the Albright court asserted a significant interest in applying a measure of objective reasonableness to fear-of-cancer claims. With this in mind, the court held that to recover emotional distress damages for fear of contracting a latent disease in Maryland, a plaintiff must show that: (1) he was actually exposed to a toxic substance due to the defendant's tortious conduct, (2) which led him to fear objectively and reasonably that he would contract a disease, and (3) as a result of the objective and reasonable fear, he manifested a physical injury capable of objective determination. Under Maryland tort law, "physical injury" does not mean manifested cancer or disease, but that the injury for which recovery is sought (i.e., fear or emotional distress) is capable of objective determination, meaning testimony "must contain more than mere conclusory statements," and be sufficiently detailed "to give the jury a basis upon which to quantify the injury."

Applying this new standard, the Albright court overturned emotional damage awards for all residents who had failed to present evidence of detectable contamination in their well water for failure to meet the first prong of the prima facie standard. Applying the second prong, the court determined that even those plaintiffs who demonstrated exposure had to show contaminant levels above the regulatory standards to ensure that their fear was reasonable and objective. Finally, to ensure against the possibility of feigned claims and to prove a causal relationship to the alleged tortious conduct, the court examined whether the plaintiffs had presented sufficient evidence of a "physical injury" resulting from their objectively reasonable fear. Of the 88 plaintiffs who were originally awarded emotional damages for fear of cancer, only one plaintiff's fear-of-cancer claim survived judicial scrutiny.

In New Jersey, the law regarding fear of cancer in the absence of physical injury is not well settled. In 1985, the Superior Court recognized that plaintiffs suffering from present manifestations of asbestos-related disease may recover for "serious fear or emotional distress or a clinically diagnosed phobia of cancer" if the fear is reasonable and proximately caused by exposure to asbestos. Devlin v. Johns-Manville Corp. The Devlin court distinguished its decision from the Superior Court's 1983 dismissal of "cancerphobia" claims by plaintiffs not presently suffering from physical illness as a result of their ingestion of pollutants in Ayers v. Jackson Twp. In Ayers, the Superior Court had noted that without a present "substantial bodily injury or sickness" which resulted from knowledge that plaintiffs have ingested contaminants, "the task of evaluating and quantifying each person's apprehension in every groundwater pollution case, each of which might involve hundreds, if not thousands of residents, would become prodigious."

Subsequently, in 1989, the New Jersey Supreme Court affirmed that a claim for emotional distress damages based on a reasonable fear of future disease is clearly cognizable where the plaintiff's exposure to asbestos has resulted in a present physical injury. Mauro v. Raymark Indus. However, the Mauro court left the door open for fear-of-cancer claims absent physical injury by explaining that it was not addressing the question of whether exposure to toxic chemicals without the manifestation of physical injury could sustain a claim for emotional distress based on a reasonable fear of future disease.

Since the Mauro opinion, no New Jersey court has set specific prima facie standards for claims of emotional distress from fear of cancer in the absence of physical injury. But because New Jersey's reported decisions related to fear-of-cancer claims preceded the Potter and Albright decisions, and based upon the court's expressed desire to avoid speculative claims, it is likely that New Jersey courts would adopt a prima facie standard for claims of emotional distress from fear of cancer similar to Potter or Albright, if confronted with the issue.

The prima facie standards set by the Potter and Albright courts are not without criticism. The uncertain science regarding the genesis and latency of cancer could cause a person exposed to carcinogenic compounds to experience some level of emotional distress from fear of developing cancer. Plaintiffs' advocates would also argue that victims of toxic torts do not choose to be exposed to carcinogenic compounds, and therefore deserve a means of compensation for any genuine, reasonable emotional distress that results. Critics of the Potter and Albright standards would also argue that the prima facie standards require plaintiffs to expend significant amounts of money for toxicology and epidemiology experts, and are too stringent and difficult to meet. However, a clear message has been sent: In the eyes of the judiciary, setting standards which ensure that plaintiffs' fear-of-cancer claims are genuine and objectively reasonable is prudent and necessary.

Reprinted with permission from the March 3, 2014 edition of New Jersey Law Journal

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.